MedTrace Logo

Tolerability and Efficacy of Anti-Aging Treatment Regimen in Subjects With Photodamage

NCT02422836 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2015-04-21

No results posted yet for this study

Summary

The subjects will use the test skincare products. This is a full face, twice daily application study, with digital photos and expert grader evaluations at Baseline, 4 and 8 week periods. If the subject meets the study criteria and is enrolled, they will be instructed at screening visit to discontinue the use of any facial products (except dry mineral foundation and eye make-up) for seven (7) days before beginning the study (referred to as the "washout" period). They will return to the site for the baseline visit 2 after the required 7 day washout period (visit can occur within 1 week after screening visit).

Conditions

  • Skin Manifestations

Interventions

OTHER

Three Product Anti-Aging Treatment Regimen

Cream Skin Cleanser RD04033B, twice daily, 8 weeks; Anti-aging Cream RD04034B, twice daily, 8 weeks; and Sunscreen SPF 50 RD04036, once daily, reapply as needed, 8 weeks

Sponsors & Collaborators

  • US CosmeceuTechs, LLC

    lead INDUSTRY

Principal Investigators

  • Bruce Katz, MD · JUVA Skin & Laser Center / MediSpa

Study Design

Allocation
NA
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2013-05-31
Completion
2013-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02422836 on ClinicalTrials.gov